Moon Surgical adds 5G and Wi-Fi to Maestro robots for cloud-based AI
Targeting a soft-tissue market led by Intuitive Surgical, Moon has invested in digital capabilities to try to differentiate its robots from the competition. AI hardware leader Nvidia co-led Moon’s $55.4 million financing round in 2023. Moon received Food and Drug... Read More →
NeuroBionics Announces Oversubscribed $10M Seed Round with Second Close Led by Future Ventures
Financing strengthens momentum as the company advances its endovascular neuromodulation platform toward first-in-human studies. NeuroBionics today announced the completion of its oversubscribed seed round, marking significant momentum as the company advances its endovascular neuromodulation platform toward first-in-human studies. The second... Read More →
AeviceMD Achieves Australia TGA Certification
Singapore, 16 Dec 2025 — AeviceMD Monitoring System, a non-invasive wearable respiratory monitoring solution developed by Aevice Health, has been included in the Australian Register of Therapeutic Goods (ARTG) as a Class IIa medical device. This milestone marks an important... Read More →
RIVANNA announces FDA clearance of Accuro 3S Needle Guide Kit
CHARLOTTESVILLE, Va., Dec. 16, 2025 /PRNewswire/ — RIVANNA®, developer of world-first imaging-based medical technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Accuro® 3S Needle Guide Kit consumables. This clearance marks a... Read More →
Teal Health Partners with Thatch Marketplace to Increase Employee Access to At-Home Cervical Cancer Screening
SAN FRANCISCO, Dec. 16, 2025 /PRNewswire/ — Teal Health, a virtual women’s health platform and the creators of the first and only FDA-authorized self-collection device for at-home cervical cancer screening, today announced the availability of their services on the Thatch... Read More →
Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering
London, UK and Chicago, IL – 15 December 2025 – Leucid Bio (“Leucid” or the “Company”), a privately-held biotechnology company developing innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies using its proprietary lateral CAR platform, and Syenex, an open-science genetic medicines... Read More →
FDA Approves the Zenflow Spring® Implant and Delivery System for First-Line Interventional Therapy of Patients with Benign Prostatic Hyperplasia (BPH)
Long-Term Data Supports Three-Year Durability Innovative Design Allows for Only Tailored BPH Approach that Preserves Natural Anatomy SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) — Zenflow, Inc. announced today the U.S. Food and Drug Administration (FDA) approval of... Read More →
Neurovalens granted FDA medical approval for weight management device
Neurovalens, a global leader in non-invasive neuro-technology, has been granted medical device De Novo approval from the US Food & Drug Administration (FDA) for Modius Lean, its prescribed treatment for weight management. Based in Belfast, Northern Ireland, Neurovalens is a... Read More →
CathVision Announces Appointment of Eric Thepaut as Independent Chairman of the Board and Releases ECGenius® System Version 3.5
COPENHAGEN, Denmark, Dec. 10, 2025 /PRNewswire/ — CathVision, a medical technology company dedicated to improving clinical outcomes in cardiac electrophysiology through high-fidelity signal acquisition and intelligent software, today announced two major milestones: the appointment of Eric Thepaut as independent Chairman... Read More →
Launch Tennessee announces FY26 SBIR/STTR Matching Fund companies, surpasses $1 billion in economic impact featuring Winter Innovations,
Launch Tennessee announces FY26 SBIR/STTR Matching Fund companies, surpasses $1 billion in economic impact Nashville, TN – Launch Tennessee today announced the 32 companies selected for its FY26 SBIR/STTR Matching Fund, marking a historic milestone as the program surpasses $1... Read More →